Sai Life Sciences Ltd carries out contract research and manufacturing activities for customers engaged in pharmaceutical and bio technology industriesBusiness Overview: a) SLS is a Hyderabad-based contract research development and manufacturing organisation in the pharmaceutical sector with a significant presence in regulatory markets of US and Europe. b) It offers...
Sai Life Sciences officials are set to participate in the Jefferies 5th India Forum on September 18, 2026. They will engage in group and one-on-one meetings in Gurgaon, discussing publicly available company information.
Sai Life Sciences Limited officials will attend Morgan Stanley's 24th Annual Global Healthcare Conference in New York on Monday, September 14, 2026. These in-person group and one-on-one meetings will involve discussions based on publicly available information, with no unpublished price sensitive information to be shared.
Sai Life Sciences Limited has informed the Exchange regarding Allotment of 80600 Shares.
Sai Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication
Sai Life Sciences is sending web-link letters to shareholders without registered emails. This provides access to the Integrated Annual Report for FY25-26 ahead of the 27th Annual General Meeting on September 17. Shareholders are advised to register their emails for future communications.
